Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingel Demedts

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Acta Cardiologica|November 29, 2013
Malignant cardiac tamponadeMichel de Ceuninck, Ingel Demedts, Sander Trenson
Journal of Chemotherapy (Florence, Italy)|January 6, 2025
An acquired CCDC6::<i>RET</i> gene fusion as resistance mechanism for Osimertinib in exon 21 <i>EGFR(L858R)</i>-mutated non-small cell lung cancer and its successful management with Osimertinib and Selpercatinib: a case report and review of literatureMaud Lormans, Peter Van Haecke, Ingel Demedts
European Journal of Cancer Care|July 12, 2022
Evaluation of the implementation of Value-Based Healthcare with a weekly digital follow-up of lung cancer patients in clinical practiceSarah Misplon, Wim Marneffe, Ulrike Himpe, et al.
Advances in Therapy|May 17, 2023
Indirect Costs Due to Lung Cancer-Related Premature Mortality in Four European CountriesGoran Bencina, Nour Chami, Robert Hughes, et al.
Molecular Diagnosis & Therapy|August 13, 2015
Antitumoral activity of tyrosine kinase inhibitors in patients with non-small cell lung cancer harbouring rare epidermal growth factor receptor mutationsMatthijs Oyaert, Ingel Demedts, Elke Boone, et al.
Scientific Reports|August 6, 2024
Patient-centric thresholding of Cobas® EGFR mutation Test v2 for surveillance of EGFR-mutated metastatic non-small cell lung cancerJonas Claus, Dieter De Smet, Joke Breyne, et al.
Therapeutic Advances in Respiratory Disease|September 6, 2011
Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: a retrospective observational studyMathieu Coeman, Yannick van Durme, Fre Bauters, et al.
Drugs - Real World Outcomes|March 12, 2021
Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL StudyKristof Cuppens, Liesbet Lodewyckx, Ingel Demedts, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 31, 2008
Matrix metalloproteinases -8, -9 and -12 in smokers and patients with stage 0 COPDHelen Ilumets, Paula Rytilä, Ingel Demedts, et al.
Respiratory Medicine and Research|October 2, 2025
Impact of the COVID-19 pandemic on lung cancer diagnosis, treatment, mortality, and survival in Belgium: A population-based studyHanne Peirelinck, Hanna M Peacock, Geert Silversmit, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Acta Cardiologica|November 29, 2013
Malignant cardiac tamponadeMichel de Ceuninck, Ingel Demedts, Sander Trenson
Journal of Chemotherapy (Florence, Italy)|January 6, 2025
An acquired CCDC6::<i>RET</i> gene fusion as resistance mechanism for Osimertinib in exon 21 <i>EGFR(L858R)</i>-mutated non-small cell lung cancer and its successful management with Osimertinib and Selpercatinib: a case report and review of literatureMaud Lormans, Peter Van Haecke, Ingel Demedts
European Journal of Cancer Care|July 12, 2022
Evaluation of the implementation of Value-Based Healthcare with a weekly digital follow-up of lung cancer patients in clinical practiceSarah Misplon, Wim Marneffe, Ulrike Himpe, et al.
Advances in Therapy|May 17, 2023
Indirect Costs Due to Lung Cancer-Related Premature Mortality in Four European CountriesGoran Bencina, Nour Chami, Robert Hughes, et al.
Molecular Diagnosis & Therapy|August 13, 2015
Antitumoral activity of tyrosine kinase inhibitors in patients with non-small cell lung cancer harbouring rare epidermal growth factor receptor mutationsMatthijs Oyaert, Ingel Demedts, Elke Boone, et al.
Scientific Reports|August 6, 2024
Patient-centric thresholding of Cobas® EGFR mutation Test v2 for surveillance of EGFR-mutated metastatic non-small cell lung cancerJonas Claus, Dieter De Smet, Joke Breyne, et al.
Therapeutic Advances in Respiratory Disease|September 6, 2011
Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: a retrospective observational studyMathieu Coeman, Yannick van Durme, Fre Bauters, et al.
Drugs - Real World Outcomes|March 12, 2021
Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL StudyKristof Cuppens, Liesbet Lodewyckx, Ingel Demedts, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 31, 2008
Matrix metalloproteinases -8, -9 and -12 in smokers and patients with stage 0 COPDHelen Ilumets, Paula Rytilä, Ingel Demedts, et al.
Respiratory Medicine and Research|October 2, 2025
Impact of the COVID-19 pandemic on lung cancer diagnosis, treatment, mortality, and survival in Belgium: A population-based studyHanne Peirelinck, Hanna M Peacock, Geert Silversmit, et al.
Pageof 3